| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G HSP90B1 MYO5A EIF4A3 SMC4 ABCB6 MSH3 KIF7 RAD50 ATP12A ABCD2 ATP4A HSPA9 TOP2A TOP2B SLC27A4 KIF2C | 3.97e-05 | 614 | 179 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.11e-04 | 11 | 179 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.90e-04 | 13 | 179 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | P-type potassium:proton transporter activity | 2.38e-04 | 3 | 179 | 2 | GO:0008900 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 2.40e-04 | 14 | 179 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.98e-04 | 15 | 179 | 3 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.64e-04 | 16 | 179 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 4.74e-04 | 4 | 179 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 4.74e-04 | 4 | 179 | 2 | GO:0003918 | |
| GeneOntologyBiologicalProcess | synaptic signaling | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 LRIT3 CHRNB2 PRR7 TBC1D24 SLC6A3 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 AKAP9 PRKAR2A DLG3 TNR LARGE1 | 9.88e-07 | 976 | 177 | 25 | GO:0099536 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 CHRNB2 TBC1D24 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 PRKAR2A TNR LARGE1 | 1.14e-06 | 663 | 177 | 20 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 CHRNB2 TBC1D24 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 PRKAR2A TNR LARGE1 | 1.17e-06 | 664 | 177 | 20 | GO:0099177 |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 DOCK1 CLSTN3 ERBB4 PRMT8 MYO5A LILRB2 NTNG1 LRIT3 CHRNB2 CDKL5 IGF1R NF1 PTPRD SHANK2 PLXNC1 GPC4 TNR KIF2C LARGE1 | 1.88e-06 | 685 | 177 | 20 | GO:0050808 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 CHRNB2 TBC1D24 SLC6A3 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 AKAP9 PRKAR2A DLG3 TNR LARGE1 | 5.09e-06 | 931 | 177 | 23 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 CHRNB2 TBC1D24 SLC6A3 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 AKAP9 PRKAR2A DLG3 TNR LARGE1 | 5.09e-06 | 931 | 177 | 23 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 LILRB2 NTNG1 ZZEF1 CHRNB2 TBC1D24 SLC6A3 SLC6A6 CDKL5 RNF167 IGF1R NF1 PTPRD SHANK2 AKAP9 PRKAR2A DLG3 TNR LARGE1 | 5.86e-06 | 939 | 177 | 23 | GO:0099537 |
| GeneOntologyBiologicalProcess | associative learning | 1.67e-05 | 130 | 177 | 8 | GO:0008306 | |
| GeneOntologyBiologicalProcess | melanosome assembly | 1.84e-05 | 19 | 177 | 4 | GO:1903232 | |
| GeneOntologyBiologicalProcess | cell junction organization | SHANK1 DOCK1 CLSTN3 ERBB4 PRMT8 MYO5A LILRB2 NTNG1 LRIT3 CHRNB2 CDKL5 IGF1R NF1 PTPRD SHANK2 PLXNC1 GPC4 MMP14 TNR TBCD KIF2C LARGE1 | 3.29e-05 | 974 | 177 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | dephosphorylation | HSP90B1 RNGTT LILRB2 MTMR1 SMG5 PTPRU PPP4R3B PTPRD DUSP29 NUAK1 MTMR14 FIG4 | 4.79e-05 | 347 | 177 | 12 | GO:0016311 |
| GeneOntologyBiologicalProcess | platelet dense granule organization | 5.76e-05 | 25 | 177 | 4 | GO:0060155 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 6.12e-05 | 115 | 177 | 7 | GO:0035418 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 6.18e-05 | 49 | 177 | 5 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 6.18e-05 | 49 | 177 | 5 | GO:0099633 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 7.32e-05 | 2 | 177 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | cognition | SHANK1 CLSTN3 WASHC4 EIF4A3 LILRB2 ZZEF1 CHRNB2 SLC6A3 NF1 SHANK2 AP1S2 TNR LARGE1 | 7.73e-05 | 423 | 177 | 13 | GO:0050890 |
| GeneOntologyBiologicalProcess | learning | 9.31e-05 | 212 | 177 | 9 | GO:0007612 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | CDC42BPG FLT1 ERBB4 PRMT8 EOGT EID3 DPY19L1 RET NSMCE3 ZZEF1 IFNA8 TBC1D24 IGF1R AKAP9 CSNK1D CSNK1E RPS6KA6 DLG3 PRKDC TAF1 PLK1 | 1.00e-04 | 976 | 177 | 21 | GO:0018193 |
| GeneOntologyBiologicalProcess | pigmentation | 1.04e-04 | 125 | 177 | 7 | GO:0043473 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.46e-04 | 132 | 177 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | cellular pigmentation | 2.23e-04 | 64 | 177 | 5 | GO:0033059 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 2.37e-04 | 101 | 177 | 6 | GO:0097120 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SHANK1 NTNG1 LAMC3 RET GDI1 CHRNB2 TBC1D24 CDKL5 IGF1R PTPRD PLXNC1 CCR5 TNR PLS1 TOP2B TBCD CLRN2 | 2.53e-04 | 748 | 177 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 2.95e-04 | 148 | 177 | 7 | GO:1902414 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 3.08e-04 | 38 | 177 | 4 | GO:1902473 | |
| GeneOntologyBiologicalProcess | melanosome organization | 3.41e-04 | 39 | 177 | 4 | GO:0032438 | |
| GeneOntologyBiologicalProcess | pigment granule organization | 3.76e-04 | 40 | 177 | 4 | GO:0048753 | |
| GeneOntologyBiologicalProcess | learning or memory | SHANK1 CLSTN3 EIF4A3 LILRB2 ZZEF1 CHRNB2 NF1 SHANK2 AP1S2 TNR LARGE1 | 3.93e-04 | 373 | 177 | 11 | GO:0007611 |
| GeneOntologyBiologicalProcess | GDF15-GFRAL signaling pathway | 4.34e-04 | 4 | 177 | 2 | GO:0160144 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from endosome | 4.34e-04 | 4 | 177 | 2 | GO:0016182 | |
| GeneOntologyBiologicalProcess | regulation of hematopoietic stem cell differentiation | 4.61e-04 | 18 | 177 | 3 | GO:1902036 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SHANK1 DOCK1 CLSTN3 ERBB4 MYO5A VPS26B EIF4A3 NTNG1 PRR7 CDKL5 IGF1R NF1 PTPRD SHANK2 AKAP9 PLXNC1 GPC4 PRKAR2A DLG3 OLFM2 TNR KIF2C | 2.05e-06 | 817 | 179 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | membrane protein complex | MAGEL2 BTBD8 VPS26B LILRB2 BEST3 ABCB6 RET NDUFS3 CHRNB2 RYR2 SLC6A3 SLC6A6 KCNH6 IGF1R TRPM5 AKAP9 KCNH2 AP5B1 AP1S2 DLG3 OLFM2 OSMR AP4B1 ATP12A NCF1C NCF1B ATP4A HSPA9 | 7.59e-05 | 1498 | 179 | 28 | GO:0098796 |
| GeneOntologyCellularComponent | potassium:proton exchanging ATPase complex | 2.18e-04 | 3 | 179 | 2 | GO:0005889 | |
| GeneOntologyCellularComponent | BLOC-2 complex | 2.18e-04 | 3 | 179 | 2 | GO:0031084 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | BTBD8 LILRB2 ABCB6 RET CHRNB2 SLC6A3 SLC6A6 IGF1R AKAP9 KCNH2 DLG3 OLFM2 OSMR ATP12A NCF1C NCF1B ATP4A | 4.31e-04 | 785 | 179 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | SHANK1 CLSTN3 ERBB4 NTNG1 CHRNB2 PRR7 SLC6A3 SLC6A6 PTPRD SHANK2 AKAP9 GPC4 DLG3 OLFM2 | 5.15e-04 | 583 | 179 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | transmembrane transporter complex | BEST3 ABCB6 NDUFS3 CHRNB2 RYR2 KCNH6 TRPM5 AKAP9 KCNH2 DLG3 OLFM2 ATP12A ATP4A | 5.93e-04 | 523 | 179 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 7.54e-04 | 48 | 179 | 4 | GO:0030119 | |
| GeneOntologyCellularComponent | postsynaptic membrane | SHANK1 CLSTN3 ERBB4 CHRNB2 PRR7 SLC6A3 SLC6A6 SHANK2 AKAP9 DLG3 OLFM2 | 7.65e-04 | 405 | 179 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | somatodendritic compartment | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 RET GDI1 LRIT3 PRR7 SLC6A3 SLC6A6 CDKL5 IGF1R TRPM5 NF1 SHANK2 AKAP9 CSNK1E DLG3 NCF1C NCF1B CKMT1A | 8.40e-04 | 1228 | 179 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | neuronal cell body | ERBB4 MYO5A EIF4A3 RET GDI1 LRIT3 SLC6A3 SLC6A6 IGF1R TRPM5 SHANK2 AKAP9 CSNK1E DLG3 NCF1C NCF1B CKMT1A | 8.59e-04 | 835 | 179 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | transporter complex | BEST3 ABCB6 NDUFS3 CHRNB2 RYR2 KCNH6 TRPM5 AKAP9 KCNH2 DLG3 OLFM2 ATP12A ATP4A | 9.42e-04 | 550 | 179 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | BLOC complex | 9.64e-04 | 23 | 179 | 3 | GO:0031082 | |
| GeneOntologyCellularComponent | chromosomal region | FLYWCH1 EID3 SMC4 TFIP11 NSMCE3 RAD50 FBXO28 PRKDC PLK1 TOP2A KIF2C | 1.05e-03 | 421 | 179 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | dendrite | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 RET LRIT3 PRR7 SLC6A6 CDKL5 TRPM5 NF1 SHANK2 AKAP9 DLG3 NCF1C NCF1B | 1.15e-03 | 858 | 179 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 CLSTN3 ERBB4 MYO5A EIF4A3 RET LRIT3 PRR7 SLC6A6 CDKL5 TRPM5 NF1 SHANK2 AKAP9 DLG3 NCF1C NCF1B | 1.18e-03 | 860 | 179 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | SHANK1 DOCK1 CLSTN3 ERBB4 MYO5A VPS26B EIF4A3 ZZEF1 CHRNB2 PRR7 SLC6A3 SLC6A6 CDKL5 IGF1R SHANK2 AKAP9 DLG3 OLFM2 KIF2C | 1.20e-03 | 1018 | 179 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.77e-03 | 201 | 179 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | SHANK1 CLSTN3 ERBB4 PRR7 CDKL5 PTPRD SHANK2 AKAP9 PLXNC1 DLG3 OLFM2 TNR | 1.89e-03 | 523 | 179 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | clathrin adaptor complex | 2.33e-03 | 31 | 179 | 3 | GO:0030131 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.36e-03 | 157 | 179 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | Smc5-Smc6 complex | 2.52e-03 | 9 | 179 | 2 | GO:0030915 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum lumen | 2.52e-03 | 9 | 179 | 2 | GO:0033018 | |
| GeneOntologyCellularComponent | cell body | ERBB4 MYO5A EIF4A3 RET GDI1 LRIT3 SLC6A3 SLC6A6 IGF1R TRPM5 SHANK2 AKAP9 CSNK1E DLG3 NCF1C NCF1B CKMT1A | 2.67e-03 | 929 | 179 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | actin-based cell projection | 2.79e-03 | 278 | 179 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | melanosome | 2.90e-03 | 113 | 179 | 5 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 2.90e-03 | 113 | 179 | 5 | GO:0048770 | |
| GeneOntologyCellularComponent | stereocilium | 2.91e-03 | 69 | 179 | 4 | GO:0032420 | |
| MousePheno | abnormal spatial learning | SHANK1 ARSG CHRNB2 SLC6A3 NF1 PTPRD SHANK2 AP1S2 DLG3 CCR5 NCF1C NCF1B CKMT1A | 6.88e-06 | 276 | 147 | 13 | MP:0001463 |
| Domain | Tyr_Pase_AS | 6.09e-05 | 73 | 174 | 6 | IPR016130 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 8.63e-05 | 2 | 174 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 8.63e-05 | 2 | 174 | 2 | PF00204 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 8.63e-05 | 2 | 174 | 2 | IPR018522 | |
| Domain | Topo_IIA | 8.63e-05 | 2 | 174 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 8.63e-05 | 2 | 174 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 8.63e-05 | 2 | 174 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 8.63e-05 | 2 | 174 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 8.63e-05 | 2 | 174 | 2 | IPR013759 | |
| Domain | TOP4c | 8.63e-05 | 2 | 174 | 2 | SM00434 | |
| Domain | TOP2c | 8.63e-05 | 2 | 174 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 8.63e-05 | 2 | 174 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 8.63e-05 | 2 | 174 | 2 | IPR013506 | |
| Domain | DTHCT | 8.63e-05 | 2 | 174 | 2 | PF08070 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 8.63e-05 | 2 | 174 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 8.63e-05 | 2 | 174 | 2 | PF16898 | |
| Domain | Topo_IIA_A/C | 8.63e-05 | 2 | 174 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 8.63e-05 | 2 | 174 | 2 | PS00177 | |
| Domain | - | 2.21e-04 | 92 | 174 | 6 | 3.90.190.10 | |
| Domain | Protein_kinase_ATP_BS | CDC42BPG FLT1 ERBB4 RET CDKL5 IGF1R NUAK1 CSNK1D CSNK1E RPS6KA6 PLK1 SBK2 | 2.35e-04 | 379 | 174 | 12 | IPR017441 |
| Domain | Arg_repress_C-like | 2.57e-04 | 3 | 174 | 2 | IPR024946 | |
| Domain | - | 2.57e-04 | 3 | 174 | 2 | 3.30.1360.40 | |
| Domain | K_chnl_volt-dep_ERG | 2.57e-04 | 3 | 174 | 2 | IPR003967 | |
| Domain | Ribosomal_S5_D2-typ_fold | 2.71e-04 | 34 | 174 | 4 | IPR020568 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.28e-04 | 99 | 174 | 6 | IPR029021 | |
| Domain | Toprim | 5.11e-04 | 4 | 174 | 2 | PF01751 | |
| Domain | Toprim_domain | 5.11e-04 | 4 | 174 | 2 | IPR006171 | |
| Domain | TOPRIM | 5.11e-04 | 4 | 174 | 2 | PS50880 | |
| Domain | HATPase_c | 5.85e-04 | 18 | 174 | 3 | SM00387 | |
| Domain | HATPase_c | 6.90e-04 | 19 | 174 | 3 | PF02518 | |
| Domain | - | 8.06e-04 | 20 | 174 | 3 | 3.30.565.10 | |
| Domain | - | 9.34e-04 | 21 | 174 | 3 | 3.30.230.10 | |
| Domain | HATPase_C | 9.34e-04 | 21 | 174 | 3 | IPR003594 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 1.07e-03 | 22 | 174 | 3 | IPR014721 | |
| Domain | TYR_PHOSPHATASE_1 | 1.26e-03 | 86 | 174 | 5 | PS00383 | |
| Domain | P-type_ATPase_IIC | 1.26e-03 | 6 | 174 | 2 | IPR005775 | |
| Domain | PROTEIN_KINASE_ATP | CDC42BPG FLT1 ERBB4 RET CDKL5 IGF1R NUAK1 CSNK1D CSNK1E RPS6KA6 PLK1 SBK2 | 1.27e-03 | 459 | 174 | 12 | PS00107 |
| Domain | TYR_PHOSPHATASE_dom | 1.32e-03 | 87 | 174 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.32e-03 | 87 | 174 | 5 | PS50056 | |
| Domain | Kinase-like_dom | CDC42BPG FLT1 ERBB4 RET CDKL5 IGF1R NUAK1 CSNK1D CSNK1E RPS6KA6 PRKDC PLK1 SBK2 | 1.74e-03 | 542 | 174 | 13 | IPR011009 |
| Domain | Recep_L_domain | 1.76e-03 | 7 | 174 | 2 | PF01030 | |
| Domain | Furin-like | 1.76e-03 | 7 | 174 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.76e-03 | 7 | 174 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 1.76e-03 | 7 | 174 | 2 | IPR006211 | |
| Domain | - | 1.76e-03 | 7 | 174 | 2 | 3.80.20.20 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TMEM186 SRSF1 RNGTT BZW2 VPS26B SMC4 MTMR1 PTPRU KIF7 RAD50 FASN FAM120A PTPRD DUSP29 MTMR14 CSNK1D CSNK1E LTN1 PRKDC MMP14 PLK1 GFM1 PLS1 PUS7 MAN1B1 SLC27A4 KIF2C | 1.96e-12 | 974 | 183 | 27 | 28675297 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 SRSF1 WASHC4 MYO5A EIF4A3 SMC4 TFIP11 MSH3 CMAS MTPAP NDUFS3 RAD50 FASN NF1 FAM120A LTN1 BYSL PRKDC MMP14 PLK1 SRSF9 HSPA9 TOP2A TOP2B SLC27A4 KIF2C | 1.26e-08 | 1353 | 183 | 26 | 29467282 |
| Pubmed | CDC42BPG HSP90B1 SRSF1 SRSF2 EIF4A3 SMC4 TFIP11 CMAS GDI1 MTPAP NDUFS3 FASN IGF1R FAM120A AKAP9 CSNK1D CSNK1E BUD31 PRKAR2A PRKDC PFDN6 SRSF9 HSPA9 TOP2A | 4.69e-08 | 1247 | 183 | 24 | 27684187 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | HSP90B1 ERBB4 SRSF2 CCDC146 MTMR1 RET PTPRU IGF1R NF1 SHANK2 DUSP29 MTMR14 HSPA9 CKMT1A | 5.79e-08 | 420 | 183 | 14 | 28065597 |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 12270714 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSP90B1 SRSF1 SRSF2 EIF4A3 TFIP11 CMAS RAD50 FASN UTP25 NFIC BYSL PRKDC PLK1 GFM1 SRSF9 HSPA9 TOP2A TOP2B SLC27A4 KIF2C | 3.11e-07 | 989 | 183 | 20 | 36424410 |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 5.11e-07 | 13 | 183 | 4 | 20516191 | |
| Pubmed | 5.15e-07 | 90 | 183 | 7 | 15033168 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 HSP90B1 SRSF1 SRSF2 EIF4A3 SMC4 KTI12 RAD50 FASN NF1 PRKDC DEPDC7 PLK1 TOP2A KIF2C | 5.25e-07 | 582 | 183 | 15 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 SRSF1 SRSF2 EIF4A3 CARS1 SMC4 LAMC3 MSH3 NDUFS3 RAD50 FASN NF1 FAM120A CSNK1E BYSL PRKAR2A PRKDC GFM1 SRSF9 HSPA9 TOP2A TOP2B SLC27A4 CKMT1A | 5.31e-07 | 1425 | 183 | 24 | 30948266 |
| Pubmed | SHANK1 HSP90B1 SRSF1 SRSF2 BTBD8 MYO5A MTMR1 CMAS GDI1 CCDC177 NDUFS3 TBC1D24 CDKL5 FASN NF1 FAM120A TTC7B SHANK2 CSNK1D PRKAR2A DLG3 TNR HSPA9 CKMT1A | 5.72e-07 | 1431 | 183 | 24 | 37142655 | |
| Pubmed | SRSF1 RNGTT BZW2 F2RL3 EIF4A3 UBE2C MRPL27 SMC4 NDUFS3 SLC6A6 FASN FAM120A CSNK1D BYSL PLK1 PFDN6 SRSF9 HSPA9 CKMT1A | 1.02e-06 | 971 | 183 | 19 | 33306668 | |
| Pubmed | MYO1G HSP90B1 MYO5A DPY19L1 BZW2 EIF4A3 ALG11 MSH3 CMAS RAD50 FASN NF1 FAM120A PLXNC1 BYSL PRKAR2A PRKDC MAN1B1 SLC27A4 KIF2C PSD4 | 1.04e-06 | 1168 | 183 | 21 | 19946888 | |
| Pubmed | 1.11e-06 | 197 | 183 | 9 | 36604605 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | WASHC4 VPS26B EIF4A3 SMC4 MSH3 CMAS MTPAP NDUFS3 RAD50 FASN LTN1 AP1S2 PRKDC PLK1 TOP2A TOP2B | 1.13e-06 | 704 | 183 | 16 | 29955894 |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 2030943 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 29191835 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 21715554 | ||
| Pubmed | Identification of proteins interacting with the rat somatostatin receptor subtype 2. | 1.42e-06 | 5 | 183 | 3 | 11087996 | |
| Pubmed | EIF4A3 ADAM9 CARS1 PTPRU KCNH6 GCNT7 IGF1R CSNK1D KCNH2 CSNK1E RPS6KA6 PRKAR2A TAF1 MMP14 PLK1 ATP4A | 1.81e-06 | 730 | 183 | 16 | 34857952 | |
| Pubmed | Melanoregulin, product of the dsu locus, links the BLOC-pathway and OA1 in organelle biogenesis. | 2.83e-06 | 6 | 183 | 3 | 22984402 | |
| Pubmed | Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway. | 2.83e-06 | 6 | 183 | 3 | 22609948 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FLYWCH1 MRPL27 SMC4 MTMR1 BEND4 SMG5 MSH3 MTPAP KIF7 RAD50 TRAPPC13 FASN FAM120A NFIC TOP2A TOP2B KIF2C | 3.25e-06 | 857 | 183 | 17 | 25609649 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SRSF1 SRSF2 WASHC4 EIF4A3 UBE2C TFIP11 NSMCE3 MTPAP FASN SH2D4A FAM120A CSNK1E FBXO28 PRKAR2A PRKDC PLK1 PFDN6 TOP2A TOP2B TBCD | 3.35e-06 | 1155 | 183 | 20 | 20360068 |
| Pubmed | SHANK1 SRSF1 MYO5A ADAM9 GDI1 CCDC177 KIF7 RAD50 NF1 FAM120A PTPRD SHANK2 AKAP9 PRKAR2A DLG3 TNR HSPA9 KIF2C | 3.77e-06 | 963 | 183 | 18 | 28671696 | |
| Pubmed | SHANK1 HSP90B1 CLSTN3 WASHC4 MYO5A EIF4A3 ADAM9 MAGEH1 USP25 TFIP11 SMG5 MSH3 CMAS GDI1 PPP4R3B FAM120A PTPRD TTC7B PRKDC TAF1 HSPA9 | 4.60e-06 | 1285 | 183 | 21 | 35914814 | |
| Pubmed | 5.04e-06 | 22 | 183 | 4 | 22305495 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRSF1 SRSF2 MYO5A EIF4A3 MRPL27 MTPAP FASN FAM120A CSNK1E SRSF8 RARS2 PRKDC SRSF9 HSPA9 TOP2A PUS7 | 6.44e-06 | 807 | 183 | 16 | 22681889 |
| Pubmed | RNGTT BZW2 EIF4A3 NAB2 SMC4 RAD50 PPP4R3B FASN FAM120A NFIC BUD31 CPNE1 PRKDC PLK1 PFDN6 HSPA9 TOP2A TOP2B KIF2C | 6.44e-06 | 1103 | 183 | 19 | 34189442 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SHANK1 DOCK1 PRMT8 SRSF1 SRSF2 EIF4A3 SMG5 RYR2 FAM120A NFIC RARS2 PLK1 | 6.90e-06 | 462 | 183 | 12 | 31138677 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | WASHC4 DPY19L1 F2RL3 RET CMAS RAD50 RUNDC3A IGF1R NF1 AKAP9 UTP25 NUAK1 CSNK1D CSNK1E PRKAR2A PLK1 HSPA9 | 7.14e-06 | 910 | 183 | 17 | 36736316 |
| Pubmed | EIF4A3 UBE2C SMC4 MSH3 NSMCE3 CMAS CCNC RAD50 PPP4R3B FASN NFIC CPNE1 PRKDC TAF1 SRSF9 TOP2A TOP2B PUS7 | 7.62e-06 | 1014 | 183 | 18 | 32416067 | |
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 7.87e-06 | 8 | 183 | 3 | 10958799 | |
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 28345663 | ||
| Pubmed | HSP90B1 PRMT8 EIF4A3 SMC4 RAD50 FASN FAM120A MTMR14 CSNK1E BYSL PRKDC HSPA9 KIF2C | 7.97e-06 | 551 | 183 | 13 | 34728620 | |
| Pubmed | HSP90B1 SRSF1 RNGTT WASHC4 EIF4A3 MRPL27 NSMCE3 GDI1 NDUFS3 RAD50 FASN FAM120A CSNK1D BYSL PRKAR2A PRKDC PLK1 SRSF9 PLS1 HSPA9 CKMT1A | 8.21e-06 | 1335 | 183 | 21 | 29229926 | |
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 8.61e-06 | 25 | 183 | 4 | 8889551 | |
| Pubmed | 8.93e-06 | 53 | 183 | 5 | 15306695 | ||
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | EOGT RNGTT BZW2 MTMR1 PGAP4 NDUFS3 RAD50 MTMR14 LTN1 BYSL PRKAR2A PLK1 GFM1 PFDN6 SRSF9 MAN1B1 SLC27A4 | 9.60e-06 | 931 | 183 | 17 | 27432908 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSP90B1 SRSF1 MYO5A EIF4A3 SMC4 CMAS GDI1 MTPAP RAD50 FASN FAM120A CSNK1D CSNK1E BYSL PRKDC SRSF9 ATP4A HSPA9 TOP2A KIF2C | 1.16e-05 | 1257 | 183 | 20 | 36526897 |
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 19857271 | ||
| Pubmed | HSP90B1 RNGTT MYO5A BZW2 MTMR1 PTPRU CCDC61 KIF7 PPP4R3B SH2D4A PTPRD TTC7B AKAP9 DUSP29 MTMR14 LTN1 PLK1 PFDN6 | 1.20e-05 | 1049 | 183 | 18 | 27880917 | |
| Pubmed | 1.56e-05 | 208 | 183 | 8 | 11790298 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SRSF1 SRSF2 BZW2 SMC4 ALG11 GDI1 RAD50 PPP4R3B RNF167 IGF1R LOXHD1 SH2D4A NUAK1 CSNK1D CSNK1E DLG3 RARS2 AP4B1 PFDN6 SLC27A4 | 1.57e-05 | 1284 | 183 | 20 | 17353931 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF1 SRSF2 FLYWCH1 EIF4A3 TFIP11 MSH3 CMAS RAD50 NFIC SRSF8 FBXO28 BUD31 TADA2A PRKDC SRSF9 HSPA9 TOP2A TOP2B SLC27A4 KIF2C | 1.76e-05 | 1294 | 183 | 20 | 30804502 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.97e-05 | 281 | 183 | 9 | 28706196 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | BZW2 NDUFS3 FASN AKAP9 CSNK1D CSNK1E FBXO28 GPC4 PRKAR2A PRKDC HSPA9 | 2.01e-05 | 432 | 183 | 11 | 23455922 |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 2.09e-05 | 31 | 183 | 4 | 26095369 | |
| Pubmed | 2.09e-05 | 31 | 183 | 4 | 27798109 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSP90B1 CLSTN3 EOGT DPY19L1 BZW2 ADAM9 ALG11 PGAP4 LAMC3 ZZEF1 SLC6A6 IGF1R NF1 FBXO28 LTN1 MANF OSMR MAN1B1 KIF2C | 2.10e-05 | 1201 | 183 | 19 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 HSP90B1 WASHC4 FLYWCH1 DPY19L1 ADAM9 MRPL27 TFIP11 MTPAP TBC1D24 PPP4R3B FASN IGF1R PRKDC HSPA9 TOP2A TOP2B SLC27A4 TBCD | 2.15e-05 | 1203 | 183 | 19 | 29180619 |
| Pubmed | 2.16e-05 | 106 | 183 | 6 | 19394292 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSP90B1 SRSF1 SRSF2 EIF4A3 SMC4 TFIP11 MTPAP NDUFS3 PPP4R3B FASN FAM120A SRSF8 BUD31 PRKDC PLK1 SRSF9 HSPA9 TOP2A TOP2B KIF2C | 2.28e-05 | 1318 | 183 | 20 | 30463901 |
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 26919979 | ||
| Pubmed | HSP90B1 SRSF1 SRSF2 EIF4A3 SMC4 RAD50 FASN PRKDC SRSF9 HSPA9 TOP2A | 2.43e-05 | 441 | 183 | 11 | 31239290 | |
| Pubmed | HSP90B1 SRSF1 EIF4A3 SMC4 CMAS HEPH RAD50 FASN IGF1R RNASET2 PRKDC PLK1 HSPA9 | 2.44e-05 | 613 | 183 | 13 | 22268729 | |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 2.45e-05 | 161 | 183 | 7 | 36398662 | |
| Pubmed | HSP90B1 SRSF1 SRSF2 MYO5A EIF4A3 SMC4 GDI1 FASN NF1 FAM120A GPC4 PRKDC SRSF9 HSPA9 TOP2A | 2.52e-05 | 803 | 183 | 15 | 36517590 | |
| Pubmed | WASHC4 FLYWCH1 EIF4A3 DOLK SMG5 ZZEF1 HEPH TBC1D24 PPP4R3B NUAK1 CPNE1 HPS5 | 2.63e-05 | 529 | 183 | 12 | 14621295 | |
| Pubmed | HSP90B1 SRSF1 SRSF2 EIF4A3 SMC4 FASN FAM120A BYSL PRKAR2A PRKDC PLK1 SRSF9 HSPA9 CKMT1A KIF2C | 2.75e-05 | 809 | 183 | 15 | 32129710 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24048577 | ||
| Pubmed | The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1. | 2.75e-05 | 2 | 183 | 2 | 25504441 | |
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 2.75e-05 | 2 | 183 | 2 | 19222228 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 1331984 | ||
| Pubmed | Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases. | 2.75e-05 | 2 | 183 | 2 | 21164026 | |
| Pubmed | Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors. | 2.75e-05 | 2 | 183 | 2 | 8139654 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 9632646 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 1380833 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18586677 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18057185 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32103339 | ||
| Pubmed | Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation. | 2.75e-05 | 2 | 183 | 2 | 16285923 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 23592547 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 2556712 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24844881 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25925375 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 2.75e-05 | 2 | 183 | 2 | 17578914 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24361808 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26356818 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10095062 | ||
| Pubmed | SRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles. | 2.75e-05 | 2 | 183 | 2 | 22855529 | |
| Pubmed | Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. | 2.75e-05 | 2 | 183 | 2 | 14996935 | |
| Pubmed | Benzamil-mediated urine alkalization is caused by the inhibition of H+-K+-ATPases. | 2.75e-05 | 2 | 183 | 2 | 33554781 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 28700616 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 28087392 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 28472494 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25404202 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25188300 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 9155056 | ||
| Pubmed | Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. | 2.75e-05 | 2 | 183 | 2 | 8710863 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18196535 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32588892 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 2555055 | ||
| Pubmed | Polo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis. | 2.75e-05 | 2 | 183 | 2 | 24931513 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31106979 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16091284 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18056810 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24424021 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31611645 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32535049 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 3.28e-05 | 150 | 183 | 6 | chr12q23 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.00e-06 | 12 | 124 | 4 | 737 | |
| GeneFamily | ATPase H+/K+ transporting | 1.39e-04 | 3 | 124 | 2 | 1211 | |
| GeneFamily | Biogenesis of lysosomal organelles complex 2 | 1.39e-04 | 3 | 124 | 2 | 1038 | |
| GeneFamily | Topoisomerases | 6.87e-04 | 6 | 124 | 2 | 1050 | |
| GeneFamily | Phosphoinositide phosphatases | 1.35e-03 | 32 | 124 | 3 | 1079 | |
| GeneFamily | MAGE family | 2.59e-03 | 40 | 124 | 3 | 1136 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.59e-03 | 40 | 124 | 3 | 321 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | FLT1 ERBB4 DPY19L1 UBE2C CDKL5 RNF167 NF1 CSNK1D CSNK1E SRSF8 TAF1 OSMR ATP12A TOP2A | 1.29e-06 | 411 | 183 | 14 | M1047 |
| Coexpression | FIRESTEIN_PROLIFERATION | 2.28e-05 | 166 | 183 | 8 | M5354 | |
| Coexpression | BIDUS_METASTASIS_UP | 2.68e-05 | 221 | 183 | 9 | M15866 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | SRSF1 SRSF2 BZW2 EIF4A3 UBE2C SMC4 BYSL CPNE1 PRKDC PLK1 SRSF9 TOP2A PUS7 MAN1B1 KIF2C | 2.80e-05 | 612 | 183 | 15 | M4772 |
| Coexpression | CHUANG_OXIDATIVE_STRESS_RESPONSE_DN | 5.30e-05 | 11 | 183 | 3 | M12948 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.25e-05 | 199 | 183 | 8 | M5893 | |
| Coexpression | GSE27786_LSK_VS_ERYTHROBLAST_UP | 8.54e-05 | 200 | 183 | 8 | M4757 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 8.54e-05 | 200 | 183 | 8 | M8600 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP | 8.54e-05 | 200 | 183 | 8 | M6158 | |
| Coexpression | GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN | 8.54e-05 | 200 | 183 | 8 | M6146 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP | 8.54e-05 | 200 | 183 | 8 | M5066 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN | 8.54e-05 | 200 | 183 | 8 | M4030 | |
| Coexpression | HALLMARK_E2F_TARGETS | 8.54e-05 | 200 | 183 | 8 | M5925 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_LUNG_UP | 8.54e-05 | 200 | 183 | 8 | M4368 | |
| Coexpression | RHODES_CANCER_META_SIGNATURE | 9.24e-05 | 65 | 183 | 5 | M1345 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 176 | 183 | 8 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-07 | 183 | 183 | 8 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-06 | 132 | 183 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | Brain_organoid|World / Sample Type, Dataset, Time_group, and Cell type. | 1.29e-06 | 191 | 183 | 8 | d93b280124b9888cd3f199d025bd6c7a1a709f2a | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 1.29e-06 | 191 | 183 | 8 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality-16|World / Primary Cells by Cluster | 1.34e-06 | 192 | 183 | 8 | 0d6413df15dfecdffc777fb02df3aaf0c30540b1 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality|World / Primary Cells by Cluster | 1.34e-06 | 192 | 183 | 8 | 5fa5b2f250ec5ad5a232c022266f0cd01ff4a753 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.45e-06 | 194 | 183 | 8 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-06 | 198 | 183 | 8 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, condition lineage and cell class | 1.69e-06 | 198 | 183 | 8 | 614055c11d1dd2f3f2b8783ec35a8f4570cad161 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Sigmoid / Region, Cell class and subclass | 1.75e-06 | 199 | 183 | 8 | bd6f8c0f79e9a94cc0f8c6105d38851463de821c | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs|Sigmoid / shred on region, Cell_type, and subtype | 1.75e-06 | 199 | 183 | 8 | 8ee78a39729633bcbb3ab17e1dfaca33f38db569 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.82e-06 | 200 | 183 | 8 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 1.87e-06 | 140 | 183 | 7 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 155 | 183 | 7 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 157 | 183 | 7 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.25e-06 | 168 | 183 | 7 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.75e-06 | 170 | 183 | 7 | 12aa9bdb18f3bf6da2a25984d08fe9497e5570ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.29e-06 | 172 | 183 | 7 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-06 | 174 | 183 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.16e-06 | 175 | 183 | 7 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.79e-06 | 177 | 183 | 7 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 177 | 183 | 7 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.79e-06 | 177 | 183 | 7 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.45e-06 | 179 | 183 | 7 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.80e-06 | 180 | 183 | 7 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 1.02e-05 | 181 | 183 | 7 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 181 | 183 | 7 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 183 | 183 | 7 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 185 | 183 | 7 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-05 | 188 | 183 | 7 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-05 | 188 | 183 | 7 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | 1.35e-05 | 189 | 183 | 7 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-05 | 189 | 183 | 7 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.44e-05 | 191 | 183 | 7 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.49e-05 | 192 | 183 | 7 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 192 | 183 | 7 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.49e-05 | 192 | 183 | 7 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 193 | 183 | 7 | e7b2d99342e3eb4a05d298c2f124dd20bed8a743 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 194 | 183 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 194 | 183 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | BALF-PFMC|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-05 | 196 | 183 | 7 | d9a0f608e0d688d19d46e95fe73eff238aae88eb | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 196 | 183 | 7 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 196 | 183 | 7 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 196 | 183 | 7 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-05 | 198 | 183 | 7 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 198 | 183 | 7 | 604fb20ca1aaf8f07067a8e1593a30ba335891f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.82e-05 | 198 | 183 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 1.86e-05 | 133 | 183 | 6 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 199 | 183 | 7 | d7dbc551c05da32c698908348572fb0ce1166e10 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 1.88e-05 | 199 | 183 | 7 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 1.88e-05 | 199 | 183 | 7 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 199 | 183 | 7 | 6a89c3a65fa50af92585c52bec203bcff6f94efc | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 1.88e-05 | 199 | 183 | 7 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 1.88e-05 | 199 | 183 | 7 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-05 | 199 | 183 | 7 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.88e-05 | 199 | 183 | 7 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | (5)_Plasmablast|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.88e-05 | 199 | 183 | 7 | f7d2ce4066436bbfe78150b579d22371a93ba76d | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.88e-05 | 199 | 183 | 7 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.88e-05 | 199 | 183 | 7 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-05 | 199 | 183 | 7 | 1dda6116de639140c2d6f5012b7ab9ad0f737ae1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 199 | 183 | 7 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 200 | 183 | 7 | dd5b753bb1333fa502b9d3a6d65a53a9882b2451 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 183 | 7 | 0de9e7412a1725a8acd51820aa3135a112ced36c | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 183 | 7 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | Severe-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.94e-05 | 200 | 183 | 7 | 80639e0d2ddaae36ac7634a4f03e8809af7316e3 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | (52)_cycling_DCs|World / shred on Cell_type and subtype | 2.00e-05 | 201 | 183 | 7 | ad2d25d84345fdd593065516a05c5c2b5429eac0 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.30e-05 | 138 | 183 | 6 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 151 | 183 | 6 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-05 | 155 | 183 | 6 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.46e-05 | 166 | 183 | 6 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.68e-05 | 167 | 183 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.68e-05 | 167 | 183 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.90e-05 | 168 | 183 | 6 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 169 | 183 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.13e-05 | 169 | 183 | 6 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 169 | 183 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.37e-05 | 170 | 183 | 6 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 171 | 183 | 6 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 171 | 183 | 6 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 171 | 183 | 6 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 172 | 183 | 6 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 172 | 183 | 6 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.86e-05 | 172 | 183 | 6 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 172 | 183 | 6 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-05 | 172 | 183 | 6 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 173 | 183 | 6 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.11e-05 | 173 | 183 | 6 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 174 | 183 | 6 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-05 | 174 | 183 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 8.37e-05 | 174 | 183 | 6 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-05 | 175 | 183 | 6 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 175 | 183 | 6 | 0a01e0104cfa3091bc05b0f1d087c941688169a5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.64e-05 | 175 | 183 | 6 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | TMEM186 SRSF1 SMG5 PPP4R3B IGF1R SHANK2 CSNK1E PRKAR2A DLG3 OSMR LARGE1 | 6.63e-07 | 199 | 183 | 11 | 5095_DN |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 4.63e-06 | 197 | 183 | 10 | 362_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 9.52e-06 | 169 | 183 | 9 | 5231_DN | |
| Drug | Thiosemicarbazones | 1.26e-05 | 64 | 183 | 6 | ctd:D013882 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.32e-05 | 176 | 183 | 9 | 6784_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.38e-05 | 177 | 183 | 9 | 6972_DN | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.97e-05 | 195 | 183 | 9 | 6662_DN | |
| Drug | NSC302991 | SRSF1 SRSF2 ABCB6 PKDREJ RAD50 IGF1R NUAK1 ADGRG2 CSNK1D PRKDC PLK1 TOP2B | 3.05e-05 | 353 | 183 | 12 | CID000002538 |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A | RNGTT LILRB2 NAB2 SMG5 SLC6A6 TRAPPC13 PLXNC1 RPS6KA6 PRKAR2A | 3.10e-05 | 196 | 183 | 9 | 3029_DN |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A | CLSTN3 RAPGEF5 PGAP4 PKDREJ IGF1R SHANK2 ADGRG2 RHOBTB2 DLG3 | 3.10e-05 | 196 | 183 | 9 | 3210_UP |
| Drug | H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 5968_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 3759_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 5781_DN | |
| Disease | Intellectual Disability | EIF4A3 TTI2 KIF7 SLC6A3 FASN NF1 SHANK2 RHOBTB2 RNASET2 TAF1 PUS7 MAN1B1 TBCD LARGE1 | 5.08e-07 | 447 | 175 | 14 | C3714756 |
| Disease | Profound Mental Retardation | 2.02e-05 | 139 | 175 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.02e-05 | 139 | 175 | 7 | C0025363 | |
| Disease | Mental deficiency | 2.02e-05 | 139 | 175 | 7 | C0917816 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.37e-05 | 206 | 175 | 8 | C0152013 | |
| Disease | pulmonary neuroendocrine tumor (is_marker_for) | 3.50e-05 | 2 | 175 | 2 | DOID:5410 (is_marker_for) | |
| Disease | B cell deficiency (implicated_via_orthology) | 3.50e-05 | 2 | 175 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 3.78e-05 | 32 | 175 | 4 | C0149782 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.34e-05 | 12 | 175 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 4.82e-05 | 34 | 175 | 4 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 5.61e-05 | 13 | 175 | 3 | C3501611 | |
| Disease | Colorectal Carcinoma | SHANK1 CLSTN3 NTNG1 ABCB6 RET PTPRU HPS3 CDKL5 NF1 PTPRD AKAP9 DLG3 OLFM2 ABCD2 | 8.24e-05 | 702 | 175 | 14 | C0009402 |
| Disease | short QT syndrome (implicated_via_orthology) | 1.05e-04 | 3 | 175 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | Transitional cell carcinoma of bladder | 2.08e-04 | 4 | 175 | 2 | C0279680 | |
| Disease | Liposarcoma, Pleomorphic | 2.08e-04 | 4 | 175 | 2 | C0205825 | |
| Disease | exercise test | 2.17e-04 | 20 | 175 | 3 | EFO_0004328 | |
| Disease | Attention Deficit Disorder | 2.91e-04 | 22 | 175 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 2.91e-04 | 22 | 175 | 3 | C1321905 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 3.46e-04 | 5 | 175 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | Rett Syndrome, Atypical | 3.46e-04 | 5 | 175 | 2 | C2748910 | |
| Disease | Attention deficit hyperactivity disorder | 3.79e-04 | 24 | 175 | 3 | C1263846 | |
| Disease | liposarcoma | 5.16e-04 | 6 | 175 | 2 | C0023827 | |
| Disease | Liposarcoma, well differentiated | 5.16e-04 | 6 | 175 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 5.16e-04 | 6 | 175 | 2 | C0205824 | |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 5.16e-04 | 6 | 175 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 6.02e-04 | 28 | 175 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | FLT1 ERBB4 SRSF1 UBE2C ABCB6 PKDREJ NDUFS3 SLC6A3 FASN IGF1R NF1 PTPRD AKAP9 CSNK1D MMP14 TOP2A | 6.95e-04 | 1074 | 175 | 16 | C0006142 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 7.20e-04 | 7 | 175 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Subwakefullness Syndrome | 7.20e-04 | 7 | 175 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 7.20e-04 | 7 | 175 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 7.20e-04 | 7 | 175 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 7.20e-04 | 7 | 175 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 7.20e-04 | 7 | 175 | 2 | C4042891 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 7.20e-04 | 7 | 175 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (is_implicated_in) | 7.20e-04 | 7 | 175 | 2 | DOID:3753 (is_implicated_in) | |
| Disease | Sleep Disorders | 7.20e-04 | 7 | 175 | 2 | C0851578 | |
| Disease | melanoma | 7.27e-04 | 248 | 175 | 7 | C0025202 | |
| Disease | Amphetamine-Related Disorders | 1.05e-03 | 75 | 175 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 1.05e-03 | 75 | 175 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 1.05e-03 | 75 | 175 | 4 | C0236804 | |
| Disease | nephroblastoma (is_marker_for) | 1.07e-03 | 34 | 175 | 3 | DOID:2154 (is_marker_for) | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.23e-03 | 9 | 175 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | Hermanski-Pudlak Syndrome | 1.53e-03 | 10 | 175 | 2 | C0079504 | |
| Disease | Short Stature, CTCAE | 1.53e-03 | 10 | 175 | 2 | C2919142 | |
| Disease | Short stature | 1.53e-03 | 10 | 175 | 2 | C0349588 | |
| Disease | Optic Atrophy | 1.53e-03 | 10 | 175 | 2 | C0029124 | |
| Disease | Hermansky-Pudlak syndrome | 1.53e-03 | 10 | 175 | 2 | cv:C0079504 | |
| Disease | plasma trimethylamine N-oxide measurement | 1.53e-03 | 10 | 175 | 2 | EFO_0005691 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.53e-03 | 10 | 175 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.60e-03 | 39 | 175 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | personality trait | 1.60e-03 | 39 | 175 | 3 | EFO_0004365 | |
| Disease | Cutaneous Melanoma | 1.85e-03 | 41 | 175 | 3 | C0151779 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.86e-03 | 11 | 175 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Congenital long QT syndrome | 1.86e-03 | 11 | 175 | 2 | cv:C1141890 | |
| Disease | visual epilepsy (is_implicated_in) | 1.86e-03 | 11 | 175 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | placenta growth factor measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0010626 | |
| Disease | Long QT Syndrome | 1.86e-03 | 11 | 175 | 2 | C0023976 | |
| Disease | attention function measurement | 1.94e-03 | 148 | 175 | 5 | EFO_0007636 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 1.99e-03 | 42 | 175 | 3 | DOID:8991 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.17e-03 | 152 | 175 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 2.22e-03 | 12 | 175 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Long QT syndrome | 2.22e-03 | 12 | 175 | 2 | cv:C0023976 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.22e-03 | 12 | 175 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Anxiety States, Neurotic | 2.27e-03 | 44 | 175 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 2.27e-03 | 44 | 175 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 2.27e-03 | 44 | 175 | 3 | C0003469 | |
| Disease | Adenocarcinoma of large intestine | 2.60e-03 | 96 | 175 | 4 | C1319315 | |
| Disease | Respiratory Depression | 2.61e-03 | 13 | 175 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.61e-03 | 13 | 175 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.61e-03 | 13 | 175 | 2 | C1145670 | |
| Disease | oral cavity cancer | 3.04e-03 | 14 | 175 | 2 | EFO_0005570 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 3.04e-03 | 14 | 175 | 2 | DOID:10873 (is_marker_for) | |
| Disease | Hepatic fibrosis | 3.09e-03 | 49 | 175 | 3 | HP_0001395 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.23e-03 | 102 | 175 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Aganglionosis, Colonic | 3.49e-03 | 15 | 175 | 2 | C0085758 | |
| Disease | Opioid use measurement | 3.49e-03 | 15 | 175 | 2 | EFO_0009937 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 3.49e-03 | 15 | 175 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Aganglionosis, Rectosigmoid Colon | 3.49e-03 | 15 | 175 | 2 | C1257840 | |
| Disease | urinary bladder cancer (is_marker_for) | 3.84e-03 | 107 | 175 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Romano-Ward Syndrome | 3.97e-03 | 16 | 175 | 2 | C0035828 | |
| Disease | thyroid volume | 3.97e-03 | 16 | 175 | 2 | EFO_0004865 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 3.97e-03 | 16 | 175 | 2 | C1257877 | |
| Disease | Peripheral Nervous System Diseases | 4.07e-03 | 54 | 175 | 3 | C4721453 | |
| Disease | Metastatic melanoma | 4.07e-03 | 54 | 175 | 3 | C0278883 | |
| Disease | leukemia | 4.29e-03 | 55 | 175 | 3 | C0023418 | |
| Disease | Alzheimer's disease (is_marker_for) | 4.44e-03 | 257 | 175 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Congenital Intestinal Aganglionosis | 4.49e-03 | 17 | 175 | 2 | C3661523 | |
| Disease | Breast Carcinoma | 4.99e-03 | 538 | 175 | 9 | C0678222 | |
| Disease | Adrenocortical carcinoma | 5.03e-03 | 18 | 175 | 2 | C0206686 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 5.20e-03 | 352 | 175 | 7 | EFO_0007015 | |
| Disease | Malignant neoplasm of skin | 5.23e-03 | 59 | 175 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 5.23e-03 | 59 | 175 | 3 | C0037286 | |
| Disease | cancer (implicated_via_orthology) | 5.42e-03 | 268 | 175 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 5.60e-03 | 19 | 175 | 2 | MONDO_0018469 | |
| Disease | Pheochromocytoma | 5.60e-03 | 19 | 175 | 2 | C0031511 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSIYKLLYREFIVFA | 26 | Q8N1M1 | |
| VFLRKRYLVEDSLYP | 131 | Q2TAA5 | |
| ETSSYRKLERYGEFL | 111 | Q96M60 | |
| RGTKLYEDRYALAIF | 106 | Q15303 | |
| EVQIVDYKYRELGFL | 396 | Q5NDL2 | |
| DYKYRELGFLDQLRI | 401 | Q5NDL2 | |
| YRRYADTLFDILVAG | 61 | Q9Y6E2 | |
| RDGLEKRYIASYLAL | 56 | Q9NUN7 | |
| FDLFYKRKAISRELY | 61 | P41223 | |
| IYGKYLRAESFRKAL | 3701 | Q99996 | |
| SKRYLILIYSVEFDR | 116 | Q9Y6R9 | |
| VERLYRAAVTEGKLY | 146 | Q9BQT9 | |
| LVAEEAHRKGYLRYV | 281 | Q9UBJ2 | |
| RYLIRFVFTTDELKY | 416 | Q6ZU67 | |
| TLVTYIAFEKIRRDY | 646 | Q8IZP9 | |
| LFYYRLLLVGIDEVK | 516 | Q9Y6B7 | |
| YEVERYREAIIKYQG | 471 | Q9NP58 | |
| QTVRLERYKAFYITG | 421 | Q96EG1 | |
| KQTVFYLEDYLTVRR | 336 | Q9NR22 | |
| YLEDYLTVRRGEEIY | 341 | Q9NR22 | |
| DLVKELLFDAIGRYY | 296 | Q96QD5 | |
| LDLVRRYFGEKIGLY | 336 | Q32M45 | |
| SFRQYLEESLGKLRY | 1021 | Q9P1Z9 | |
| IYAFVGEKFRNYLLV | 296 | P51681 | |
| YYKTGILERVDRRLV | 236 | Q9UKW6 | |
| ARSIVEYREYIGGFK | 61 | Q7L9B9 | |
| GEYATYEAIRKAFRV | 136 | P50281 | |
| LDSYYRTIKGFETLV | 456 | Q13613 | |
| YYKGRRVLEFRTLGD | 236 | O95897 | |
| RYDFRIYGLSTKRIA | 596 | Q99650 | |
| LLGRSEYVEKFYRIK | 1276 | Q92878 | |
| FLYGTEKVRLTYLRN | 1366 | Q6DT37 | |
| VYEFIYLVRDCGIRT | 66 | Q86WS3 | |
| YLIGDVYVERIIVRL | 786 | O94822 | |
| RFYARYSLKSIDPVL | 71 | P24863 | |
| EIIHRYVELLDKYFG | 81 | P56377 | |
| EYRKLLTVVVDAFYV | 56 | D6REC4 | |
| GEVAVLKRDGRYIYY | 66 | Q9Y530 | |
| GIAIAYATLEYFIRD | 986 | P20585 | |
| YLTFLEYDGNLLRRE | 401 | O95461 | |
| VTEEFVRRGYLIYKP | 136 | Q9H213 | |
| LITEVFVRQKYLEYR | 1156 | Q9UJ55 | |
| IFLEYVRYFRIKPLG | 371 | Q9UPQ8 | |
| KGDYLKELFRRYGDI | 166 | O60942 | |
| VILDSLNYIKGFRYE | 76 | Q96EK9 | |
| FLSYEELLQRRLGKY | 156 | Q86UX2 | |
| LFDKVRGYDIKLLRY | 191 | Q8NCE2 | |
| KEEEIRKYSIIYGRF | 291 | Q15742 | |
| DLFVELKRYYVVGNV | 141 | O75487 | |
| YQLREFKSEYRVVAL | 111 | Q8IUS5 | |
| FKSEYRVVALDLRGY | 116 | Q8IUS5 | |
| LVYESFLYRREKAAG | 431 | Q4VC44 | |
| GSFLVYESFLYRREK | 516 | Q4VC44 | |
| VYDEVRKLFIRLYPG | 1016 | P54707 | |
| LLTDYIAFVEKSGYR | 66 | Q8WXJ9 | |
| YATRLYEKFGESALR | 851 | Q9UPZ3 | |
| REDLLRGIYAYGFEK | 46 | P38919 | |
| ARKLDRYSEYGAAVL | 536 | Q12809 | |
| VARKLDRYSEYGAAV | 386 | Q9H252 | |
| RLERLFYEKEYTGDR | 1366 | Q8IVV2 | |
| ILLISKAEDYRSYRF | 61 | P08069 | |
| VERILGLLQTYFRKY | 221 | Q8N140 | |
| VGKRLDYITAEIKRY | 76 | O15212 | |
| YAISVARKIGARIYA | 586 | Q14651 | |
| NIYIYLTAGKEVRRI | 436 | O60486 | |
| DGREVNFYKIIDYIL | 311 | P51160 | |
| YIIDFGLAKKYRDAR | 146 | P48730 | |
| YEDAGLRARTKIVYS | 576 | Q2PZI1 | |
| YEARIQALEKELGRY | 1186 | Q2M1P5 | |
| YDRFVLYKEGERDLR | 251 | Q8N423 | |
| ITLKDVFDDGRYVYL | 481 | Q9UK32 | |
| KTVIRRISAEAFYYL | 66 | Q3SXY7 | |
| YSLELRFRVEGQLYA | 691 | Q2VPB7 | |
| DKVIRFKRAIGYYSA | 316 | Q9NZB2 | |
| LYSLLRAKGERAYVV | 366 | Q9BRR3 | |
| RIIGLKDEFYNRYIT | 596 | Q5MIZ7 | |
| YIYGALDSRVRALVF | 341 | Q9NVV4 | |
| TFYATKRLIGRRYDD | 116 | P38646 | |
| AVLLYEYVGKRIVDL | 41 | Q8N6N6 | |
| EEKRGITARELYSYL | 476 | Q9UBG3 | |
| YLGRFYQDLKDRDVT | 36 | P55145 | |
| LSEKVVYRRFTEIYE | 36 | A6NI72 | |
| LSEKVVYRRFTEIYE | 11 | A8MVU1 | |
| VESLFYLYRVTGDRK | 601 | Q9UKM7 | |
| IIVIIRKGRDHYAYS | 766 | Q92729 | |
| YSEVLTDTRGLYRKI | 166 | Q8TB68 | |
| YYVSAEFRDKVRAGL | 341 | Q96RI0 | |
| SDYIKLYVRRVFITD | 406 | P14625 | |
| FLRGKVFIYRGKEYE | 1351 | Q14185 | |
| IRRELYYFGVKVCII | 186 | Q8NEX9 | |
| KLYIGDEATALDRYR | 61 | Q68J44 | |
| YYVLTRKFVEFILTD | 281 | Q6ZNI0 | |
| FLEGYYIVLITKRRK | 101 | Q92562 | |
| YLSEGRYRLGDKILF | 236 | Q86XJ1 | |
| GLKEVAIYILRRDYC | 291 | Q5XKL5 | |
| GKVIDEIYRVLRYVN | 171 | Q9NVF7 | |
| TIFAVGRYLEKYLER | 106 | U3KPV4 | |
| GRYLEKYLERFLETA | 111 | U3KPV4 | |
| TRYVELFIVVDKERY | 211 | Q13443 | |
| KRSLYVRALFDYDRT | 501 | Q92796 | |
| FYVIERGTYDILVTK | 176 | P13861 | |
| VNRIKLYSESLARYG | 206 | P31150 | |
| YEDSILAVRKYFQRI | 136 | P32881 | |
| TGLYEAYEAERRAKL | 131 | Q9NQR7 | |
| AQAEVYKELRLRGYD | 986 | P49327 | |
| RRGKLYLVFEYVEKN | 81 | O76039 | |
| TLTERVLYYTGRIAK | 61 | Q96RP9 | |
| LEYIHARGLVYRDLK | 171 | P0C263 | |
| KYGEFYGRDRISELL | 4656 | Q92736 | |
| RKLGLEVYVTFFEIY | 391 | Q99661 | |
| YGILIFVYDEIRKLG | 1006 | P20648 | |
| VLEVYRGVREVLSKY | 181 | Q13895 | |
| YRFETVQKLRFGIYD | 66 | Q99829 | |
| ASKIRSGYFDERYVL | 146 | P12532 | |
| ERNGIITKYTLLYRD | 946 | P23468 | |
| LTYRLYDKFAEAVGV | 106 | Q7Z6I6 | |
| VLLVKAAAFSYYRGD | 261 | Q9UNW8 | |
| LARYFYAISDIKVRG | 281 | Q9Y2I2 | |
| VYAQKGYLEELVRLR | 261 | Q59EK9 | |
| DLSIEEYIRVYKRLG | 246 | Q5T160 | |
| RYTIKGIRNLIFYEL | 676 | Q68CQ4 | |
| RRVFEKYGRVGDVYI | 31 | Q01130 | |
| DLYPSFLRKGYRREI | 416 | P31641 | |
| EDLFYKYGRIREIEL | 31 | Q13242 | |
| YISFDILRRVLKDYF | 71 | P49589 | |
| KEFFDLRLSYYGLRK | 1041 | Q02880 | |
| IRYLEAEFKKGNRYI | 906 | Q9UPR3 | |
| KTRKIYDFLIREGYI | 426 | O75478 | |
| VFVDYGYQKRVLIED | 831 | B5MCY1 | |
| EDGLQKYERGLIFYI | 596 | Q969F9 | |
| IAEQRVLRYGYFGKE | 256 | Q8NFW8 | |
| LYERALKIYEDSLGR | 1241 | Q7Z494 | |
| GYRERELFDAKIIYE | 671 | Q5H9M0 | |
| DFLIIRTRQGYYIRE | 761 | P21675 | |
| TILKTLRYSRFFYDV | 2061 | Q9NTG1 | |
| GYVELRYDDEVKRVV | 206 | O75489 | |
| LLGSRYKKAVFREYT | 776 | Q9BQS7 | |
| YRLEGFRKSEVAAYL | 596 | Q8NDX1 | |
| FRAVLKYLYTGELDE | 426 | Q9BYZ6 | |
| EYLRALFVYEKGARV | 146 | Q9H6Y7 | |
| RDYSLSGAYRKIIIR | 566 | Q96PZ0 | |
| SGRIYVYRKDLADTL | 311 | Q92565 | |
| SKGELYDYISERRRL | 136 | O60285 | |
| RRVFEKYGRVGDVYI | 31 | Q9BRL6 | |
| VAVKELDLYLAYFVR | 171 | P08651 | |
| EGVPSLEFRYKKRVY | 131 | Q9UPX8 | |
| EKGVPYLEFRYKTRV | 146 | Q9Y566 | |
| ISPRDFIDLVYIKRY | 106 | P59095 | |
| YVDITYDFIIRRKPL | 221 | P17787 | |
| TIRDGEVYYRSKYLR | 61 | Q9HAY6 | |
| EIYRRLREFAKLYDT | 506 | Q8IYE0 | |
| ILVSIFAYDAFKIYR | 196 | Q96DZ9 | |
| DRELVKFIGDIYYGL | 51 | A0PK11 | |
| VFLVEGYKVLYRVAL | 231 | Q9ULP9 | |
| QKKYFGRSLELYREL | 131 | O00584 | |
| IKIEFIGQIELYYDR | 66 | Q4G0F5 | |
| VADFLTYGRLQELYR | 406 | Q9NZQ8 | |
| LVMDELGYLYFRDRT | 491 | Q6P1M0 | |
| LKRLERVIIGYLEVY | 381 | Q6NXR4 | |
| YFIDRDGEIFRYVLS | 101 | Q96SI1 | |
| IDGIRAYLSVDFYRL | 291 | Q01959 | |
| VEDSRNLYKLRIGSY | 1246 | Q92752 | |
| TFYVTLRYGRILDRE | 186 | Q96B77 | |
| YRKFRETTMYLIIGL | 871 | Q9UHP3 | |
| VREYTKYHERLLTGL | 1686 | P21359 | |
| FEISDRLIGIYKTYN | 1256 | Q9NTJ3 | |
| LIRVSERIKGYALSY | 371 | Q9H788 | |
| GKEYYIEILLQEYRL | 456 | Q86WI1 | |
| ISIDRYLIIKYPFRE | 116 | Q9BXA5 | |
| AERLQYVFGYKLVEL | 131 | Q96MG7 | |
| KLITEDFVRQRYLEY | 221 | Q96MG7 | |
| RYKEVYAAAAEVLGL | 2311 | P78527 | |
| LAKLYRSIGEYDVLR | 2926 | P78527 | |
| LLIVEYAKYGSLRGF | 801 | P07949 | |
| LDILRDFFELRLKYY | 1016 | P11388 | |
| YRLRVIAEAYATKGL | 136 | Q86TV6 | |
| YGKFLEEYTSQLRRI | 31 | Q2M389 | |
| DYLEFTDARGRKTRY | 1136 | O43149 | |
| FYKYGAIRDIDLKNR | 36 | Q07955 | |
| LAFKFLYIITKVRGY | 101 | Q9BTW9 | |
| ALEEGIVRYTKEVYV | 91 | Q9P0M9 | |
| ARYLTRGYSLIIKDV | 381 | P17948 | |
| GLRLTDTFLKRTYEY | 386 | A5PLN9 | |
| LYTFGRIVIYIDRGV | 801 | Q9UBB9 | |
| GTVYEDLRYKLSLEF | 71 | O00762 | |
| KRDFRTYRLSLLEEY | 556 | P53350 | |
| YIIDFGLAKKYRDAR | 146 | P49674 | |
| TLRLGKAYEITYVRL | 121 | Q9Y6N6 | |
| LRFEKGRIYTYIGEV | 31 | B0I1T2 | |
| GKYIEIGFDKRYRII | 221 | Q9Y4I1 |